Related references
Note: Only part of the references are listed.A novel rationale for targeting FXI: Insights from the hemostatic microRNA targetome for emerging anticoagulant strategies
Jamie Nourse et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Overexpression of tissue factor induced atherothrombosis in apolipoprotein E-/- mice via both enhanced plaque thrombogenicity and plaque instability
Xiaoling Liu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
A non-circulating pool of factor XI associated with glycosaminoglycans in mice
Bassem M. Mohammed et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Bleeding in cardiac patients prescribed antithrombotic drugs: electronic health record phenotyping algorithms, incidence, trends and prognosis
Laura Pasea et al.
BMC MEDICINE (2019)
Inhibition of contact-mediated activation of factor XI protects baboons against S aureus-induced organ damage and death
Robert Silasi et al.
BLOOD ADVANCES (2019)
Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice
Jelle J. Posthuma et al.
SCIENTIFIC REPORTS (2019)
Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages
Paul A. Mueller et al.
CIRCULATION (2018)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Coagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice
Sandra Vorlova et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies A Scientific Statement From the American Heart Association
Alan Daugherty et al.
CIRCULATION RESEARCH (2017)
Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the US Preventive Services Task Force
Evelyn P. Whitlock et al.
ANNALS OF INTERNAL MEDICINE (2016)
Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout Mice
Reut Shnerb Ganor et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans
Fleur M. van der Valk et al.
CIRCULATION (2016)
Bradykinin: Inflammatory Product of the Coagulation System
Zonne Hofman et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2016)
Factor XI Deficiency Alters the Cytokine Response and Activation of Contact Proteases during Polymicrobial Sepsis in Mice
Charles E. Bane et al.
PLOS ONE (2016)
Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice
Tomoya Hara et al.
ATHEROSCLEROSIS (2015)
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
Harry R. Bueller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice
JaeJin An et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Factor XI Regulates Pathological Thrombus Formation on Acutely Ruptured Atherosclerotic Plaques
Maurits L. van Montfoort et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Antigen levels of coagulation factor XII, coagulation factor XI and prekallikrein, and the risk of myocardial infarction and ischemic stroke in young women
B. Siegerink et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice
Thazha P. Prakash et al.
NUCLEIC ACIDS RESEARCH (2014)
Aggregate Risk Score Based on Markers of Inflammation, Cell Stress, and Coagulation Is an Independent Predictor of Adverse Cardiovascular Outcomes
Danny J. Eapen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Genetic and Pharmacological Modifications of Thrombin Formation in Apolipoprotein E-deficient Mice Determine Atherosclerosis Severity and Atherothrombosis Onset in a Neutrophil-Dependent Manner
Julian I. Borissoff et al.
PLOS ONE (2013)
Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis
Erik I. Tucker et al.
BLOOD (2012)
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The Effects of Direct Thrombin Inhibition with Dabigatran on Plaque Formation and Endothelial Function in Apolipoprotein E-Deficient Mice
Illkyu-O. Lee et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Monocyte and Macrophage Dynamics During Atherogenesis
Klaus Ley et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Post-Operative Pharmacologic Thromboprophylaxis after Major Hepatectomy Does Peripheral Venous Thromboembolism Prevention Outweigh Bleeding Risks?
Srinevas K. Reddy et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo
Qiufang Cheng et al.
BLOOD (2010)
Early Atherosclerosis Exhibits an Enhanced Procoagulant State
Julian Ilcheff Borissoff et al.
CIRCULATION (2010)
Molecular Imaging of Activated von Willebrand Factor to Detect High-Risk Atherosclerotic Phenotype
Owen J. T. McCarty et al.
JACC-CARDIOVASCULAR IMAGING (2010)
Factor XI contributes to thrombin generation in the absence of factor XII
Dmitri V. Kravtsov et al.
BLOOD (2009)
Survival advantage of coagulation factor XI-deficient mice during peritoneal sepsis
Erik I. Tucker et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Safety and efficacy of clopidogrel in children with heart disease
Luc Mertens et al.
JOURNAL OF PEDIATRICS (2008)
Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice
Florian Bea et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events
David T. Yang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Low-dose aspirin for secondary cardiovascular prevention -: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation -: review and meta-analysis
W Burger et al.
JOURNAL OF INTERNAL MEDICINE (2005)
Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice
X Wang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Atherothrombosis: A widespread disease with unpredictable and life-threatening consequences
JF Viles-Gonzalez et al.
EUROPEAN HEART JOURNAL (2004)
Site specificity of atherosclerosis - Site-selective responses to atherosclerotic modulators
PA VanderLaan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice
RJ Westrick et al.
CIRCULATION (2001)
The characterization of mice with a targeted combined deficiency of protein C and factor XI
JCY Chan et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Atherothrombosis: A major health burden
D Leys
CEREBROVASCULAR DISEASES (2001)
Share Paper
